Dr Ryan Anthony Crawford, PHARMD is a
Pharmacist based in Linglestown, Pennsylvania. Dr Ryan Anthony Crawford is licensed to practice in Pennsylvania (license number RP451113) and his current practice location is
4300 Linglestown Rd, Linglestown, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at
(717) 648-9607.
NPI number for Dr Ryan Anthony Crawford is 1467922823 and his current mailing address is 1510 High Pointe Dr Apt G, Harrisburg, Pennsylvania. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1467922823.
Healthcare Provider's Profile
Full Name | Dr Ryan Anthony Crawford |
---|
Gender | Male |
---|
Speciality | Pharmacist |
---|
Location | 4300 Linglestown Rd, Linglestown, Pennsylvania |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
NPI Data:
- NPI Number: 1467922823
- Provider Enumeration Date: 11/28/2018
- Last Update Date: 11/28/2018
Medical Identifiers
Medical identifiers for Dr Ryan Anthony Crawford such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1467922823 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
183500000X | Pharmacist | RP451113 (Pennsylvania) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ryan Anthony Crawford is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Dr Ryan Anthony Crawford, PHARMD 1510 High Pointe Dr Apt G, Harrisburg, PA 17110-9107 Ph: (717) 648-9607 | Dr Ryan Anthony Crawford, PHARMD 4300 Linglestown Rd, Linglestown, PA 17112-9532 Ph: (717) 648-9607 |
Reviews and Comments